|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/50 | |
| A61K 35/28 |
| (11) | Patento numeris | 3286562 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16722548.1 |
| Europos patento paraiškos padavimo data | 2016-04-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/059196 |
| Data | 2016-04-25 |
| (87) | Numeris | WO 2016/170187 |
| Data | 2016-10-27 |
| (30) | Numeris | Data | Šalis |
| 15382206 | 2015-04-24 | EP |
| (72) |
DE LA ROSA, Olga, ES
DALEMANS, Wilfried, ES
|
| (73) |
TiGenix, S.A.U.,
Parque Tecnol gico de Madrid C/ Marconi, 1, 28760 Tres Cantos (Madrid),
ES
|
| (54) | BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY |
| BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY |